0001628280-21-012172.txt : 20210614
0001628280-21-012172.hdr.sgml : 20210614
20210614161148
ACCESSION NUMBER: 0001628280-21-012172
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210610
FILED AS OF DATE: 20210614
DATE AS OF CHANGE: 20210614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Erlander Mark
CENTRAL INDEX KEY: 0001651537
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35558
FILM NUMBER: 211014733
MAIL ADDRESS:
STREET 1: C/O TROVAGENE, INC.
STREET 2: 11055 FLINTKOTE AVENUE, SUITE A
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiff Oncology, Inc.
CENTRAL INDEX KEY: 0001213037
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 272004382
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-952-7570
MAIL ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Trovagene, Inc.
DATE OF NAME CHANGE: 20130304
FORMER COMPANY:
FORMER CONFORMED NAME: TrovaGene Inc.
DATE OF NAME CHANGE: 20110830
FORMER COMPANY:
FORMER CONFORMED NAME: XENOMICS INC
DATE OF NAME CHANGE: 20040719
4
1
wf-form4_162370149350115.xml
FORM 4
X0306
4
2021-06-10
0
0001213037
Cardiff Oncology, Inc.
CRDF
0001651537
Erlander Mark
C/O CARDIFF ONCOLOGY, INC.
11055 FLINTKOTE AVE
SAN DIEGO
CA
92121
1
1
0
0
Chief Executive Officer
Stock Options
7.98
2021-06-10
4
A
0
435072
0
A
2031-06-10
Common Stock
435072.0
815272
D
108,768 vest on 6/10/2022. 9,064 vest monthly for 36 months beginning on 7/10/2022 through 6/10/2025.
/s/ Mark Erlander
2021-06-14